GLUCOVANCE

This brand name is authorized in Brazil, Ecuador, France, Hong Kong, Mexico, Nigeria, Netherlands, Romania, Singapore, Tunisia, South Africa

Active ingredients

The drug GLUCOVANCE contains a combination of these active pharmaceutical ingredients (APIs):

1 Metformin UNII 786Z46389E - METFORMIN HYDROCHLORIDE

Metformin is a biguanide with antihyperglycaemic effects, lowering both basal and postprandial plasma glucose. It does not stimulate insulin secretion and therefore does not produce hypoglycaemia. Read about Metformin

2 Glibenclamide UNII SX6K58TVWC - GLYBURIDE

Glibenclamide, a second-generation, short half-life sulphonylurea, is a hypoglycaemic agent that reduces blood-glucose by stimulating insulin release by the pancreas. Sulphonylureas act on pancreatic beta-cells by inhibiting ATP-sensitive potassium channels. Read about Glibenclamide

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
GLUCOVANCE Film-coated tablet	Web Search	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A10BD02	Metformin and sulfonamides	A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BD Combinations of oral blood glucose lowering drugs
Discover more medicines within A10BD02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 525405201114411, 525405202110411, 525405203117418, 525405207112313
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 24.379-1-01-12, 24.387-1-01-12
Country: FR	Base de données publique des médicaments	Identifier(s): 63079915, 65940127, 68942820
Country: HK	Department of Health Drug Office	Identifier(s): 50965, 50966, 50967
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 565M95
Country: NG	Registered Drug Product Database	Identifier(s): 04-7609, 04-7702, B4-6067
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 65625, 65633
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W13594001, W13594002, W13594003, W13594004, W13594006, W13595001, W13595002, W13595003, W13595004, W13595006
Country: SG	Health Sciences Authority	Identifier(s): 12322P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 3183071, 3183072
Country: ZA	Health Products Regulatory Authority	Identifier(s): 36/21.2/0413